Proteochemometric modeling of the inhibition complexes of matrix metalloproteinases with N-hydroxy-2-[(phenylsulfonyl)amino]acetamide derivatives using topological autocorrelation interaction matrix and model ensemble averaging

Fernandez, M. ; Fernández L.; Caballero, J; Abreu, JI; Reyes G.

Abstract

A target-ligand QSAR approach using autocorrelation formalism was developed for modeling the inhibitory potency (pIC 50) toward matrix metalloproteinases (MMP-1, MMP-2, MMP-3, MMP-9, and MMP-13) of N-hydroxy-2-[(phenylsulfonyl)amino]acetamide derivatives. Target and ligand structural information was encoded in the Topological Autocorrelation Interaction matrix calculated from 2D topological representation of inhibitors and protein sequences. The relevant Topological Autocorrelation Interaction descriptors were selected by genetic algorithm-based multilinear regression analysis and Bayesian-regularized genetic neural network approaches. A model ensemble strategy was employed for achieving robust and reliable linear and non-linear predictors having nine topological autocorrelation interaction descriptors with square correlation coefficients of ensemble test-set fitting (R 2 test) about 0.80 and 0.87, respectively. Electrostatic and hydrophobicity/hydrophilicity properties were the most relevant on the optimum models. In addition, the distribution of the inhibition complexes on a self-organized map depicted target dependence rather than an inhibitor similarity pattern. © 2008 The Authors.

Más información

Título según WOS: Proteochemometric modeling of the inhibition complexes of matrix metalloproteinases with N-hydroxy-2-[(phenylsulfonyl)amino]acetamide derivatives using topological autocorrelation interaction matrix and model ensemble averaging
Título según SCOPUS: Proteochemometric modeling of the inhibition complexes of matrix metalloproteinases with N-hydroxy-2-[(phenylsulfonyl)amino]acetamide derivatives using topological autocorrelation interaction matrix and model ensemble averaging
Título de la Revista: CHEMICAL BIOLOGY DRUG DESIGN
Volumen: 72
Número: 1
Editorial: Wiley
Fecha de publicación: 2008
Página de inicio: 65
Página final: 78
Idioma: English
URL: http://doi.wiley.com/10.1111/j.1747-0285.2008.00675.x
DOI:

10.1111/j.1747-0285.2008.00675.x

Notas: ISI, SCOPUS